Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;9(Spec Feature):150-4.

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States

Lisa A Raedler

Zarxio (Filgrastim-sndz): First Biosimilar Approved in the United States

Lisa A Raedler. Am Health Drug Benefits. 2016 Mar.
No abstract available

PubMed Disclaimer

References

    1. Metcalf D. The colony-stimulating factors and cancer. Nat Rev Cancer. 2010; 10: 425–434. - PMC - PubMed
    1. Ventola CL. Biosimilars: part 1: proposed regulatory criteria for FDA approval. P T. 2013; 38: 270–274, 277, 287. - PMC - PubMed
    1. Silver S. Industry surveys: biotechnology. Standard & Poor's. February 2013.
    1. US Food and Drug Administration. Implementation of the Biologics Price Competition and Innovation Act of 2009. Updated March 10, 2011. www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ucm215089.htm. Accessed December 7, 2015.
    1. US Food and Drug Administration. FDA approves first biosimilar product Zarxio. Press release. March 6, 2015. www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm436648.htm. Accessed December 4, 2015.

LinkOut - more resources